Haematuria
Also known as: Blood in the urine, Visible haematuria, Macroscopic haematuria, Microscopic haematuria, Non-visible haematuria
Haematuria is the presence of erythrocytes in the urine, classified as either macroscopic (visible) or microscopic (detected via testing). Pathological aetiologies include urinary tract infections, urolithiasis, renal inflammation, malignancy, trauma, and iatrogenic bleeding post-procedure. Concurrent anticoagulant therapy does not preclude the necessity for diagnostic investigation. Clinical assessment to determine the haemorrhagic source involves urinalysis, renal function monitoring, diagnostic imaging, and specialist referral. Within a Traditional Chinese Medicine (TCM) framework, assessment may provide adjunctive symptomatic care only after urgent causes are addressed. Current clinical research has not established the efficacy of acupuncture or herbal medicine for the resolution of haematuria. A small emergency-department trial indicated potential short-term analgesia for suspected renal colic rather than haemostatic resolution; the IgA vasculitis evidence cited is a protocol lacking clinical results. Traditional patterns serve as interpretive frameworks and are not considered biomedical diagnoses.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Adhere to an individualised fluid management plan; avoid excessive hydration in cases of urinary tract obstruction or prescribed fluid restriction.
- •Maintain a precise record of urine colour, presence of coagula, dysuria, body temperature, and pharmacological changes for clinical review.
- •Cease strenuous physical activity following renal procedures until clinical clearance is provided by the treating specialist.
- •Ensure attendance at all scheduled urinalysis, renal function monitoring, and specialist consultations, even if macroscopic haematuria has resolved.
Cautions & Contraindications
- •Defer elective acupuncture and herbal initiation during unexplained active heavy bleeding or suspected post-biopsy complications pending medical assessment. This precaution is informed by the bleeding context of the paediatric biopsy cohort, not an acupuncture safety trial.[]
- •Do not advise stopping anticoagulants or antiplatelets, or add potentially interacting herbal products, without prescriber review. The supplied case highlights simultaneous bleeding and thromboembolic risk; it does not establish herbal interaction safety.[]
- •Do not use analgesic response to acupuncture as reassurance that a stone has passed or infection, obstruction or another cause has been excluded. The supplied trial measured short-term pain outcomes, not haematuria resolution.[]
- •Do not infer paediatric renal safety or efficacy from the IgA vasculitis acupuncture publication: it is a protocol without results. Children with haematuria need medical assessment before any elective adjunctive intervention.[]
When to reassess or seek care again
Medical triage precedes adjunctive care; new visible haematuria warrants prompt clinician contact rather than a trial of TCM. Once medically stable, review adjunctive care within 7–14 days using pain scores, urinary symptom frequency, fatigue and adverse events. Track clinician-requested urinalysis, haemoglobin and renal function rather than urine colour alone. Persistent or recurrent haematuria, proteinuria or deteriorating renal function requires medical reassessment and appropriate urology or nephrology referral; worsening bleeding or red flags require immediate escalation. Stop adjunctive treatment if it delays investigation or provides no measurable symptomatic benefit.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- International journal of nephrology · 2026
- BMJ open · 2025
- European heart journal. Case reports · 2026
- QJM : monthly journal of the Association of Physicians · 2025
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
